Stem cell transplant restores memory and learning in mice

In a tantalising research first, human embryonic stem cells (hESCs) have been successfully transplanted into the brains of mice and then shown to restore memory and learning, according to scientists at the University of Wisconsin-Madison. The research was published online in Nature Biotechnology on 21 April 2013. Dysfunctional basal forebrain cholinergic neurons (BFCNs), present in the medial ganglionic eminence (MGE) …

“First-in-humans” trial with cardiopoietic stem cells shows promising results

Therapy with cardiopoietic stem cells has been shown to improve heart health for people suffering from heart failure, a multi-centre clinical trial has shown. The Mayo Clinic say the trial, which was the first application in humans of lineage-guided stem cells for targeted regeneration of a failing organ, will pave the way to the development of next generation regenerative medicine …

8 Exciting Stem Cell-Based Therapies in Late Stage Development

Innovative breakthrough cell therapies in Phase III development The cell therapy industry continues to grow and as the big pharma and wider investor community increasingly turn their attention towards highly innovative stem cell-based therapies, 2013 is set to be a pivotal year for the future success of regenerative medicine. Industry-sponsored clinical trials continue to progress well with approximately 50 late …

Gil Van Bokkelen CEO @Athersys presented what should be demonstrated in successful clinical trials

Today at World Stem Cells & Regenerative Medicine Congress 2012, Gil Van Bokkelen, CEO, at Athersys, delivered a presentation about clinical trials in stem cell. Gil Van Bokkelen congratulated Osiris on approval of Prochymal for treating pediatric GvHD in Canada. This is an important event, because it demonstrates the growing regulatory acceptance of cell therapy and provides an example of …